Ulcerous colitis and infection with cytomegalovirus, Herpes simplex virus and clostridium difficile;Schwere Colitis ulcerosa und Infektion mit Cytomegalieviren, Herpes-simplex-Viren und Clostridium difficile

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 8, 2008, Pages 780-783

  Arnold, Christian N ^a   von Sanden, S ^a   Theilacker, C ^a   Blum, H E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chronic inflammatory bowel disease; Crohn's disease; Infectious colitis; Intestinal complications; Ulcerative colitis

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; FAMCICLOVIR; GANCICLOVIR; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; METRONIDAZOLE; VALACICLOVIR; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; DOSE RESPONSE; ESOPHAGITIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION SENSITIVITY; SYSTEMIC THERAPY; ULCERATIVE COLITIS;

ANTIBODIES, MONOCLONAL; BIOPSY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; COLON; COLONIC POUCHES; COLONOSCOPY; CYTOMEGALOVIRUS INFECTIONS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL AGENTS; HERPES SIMPLEX; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; ULTRASONOGRAPHY;

EID: 52149111847     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027154     Document Type: Article

References (12)

1. Henriksen M, Jahnsen J, Lygren I et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006; 12 (7): 543-550
2. Moskovitz DN, Van Assche G, Maenhout B et al. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4 (6): 760-765
3. Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353 (23): 2462-2476
4. Mylonaki M, Langmead L, Pantes A et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004; 16 (8): 775-778
5. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006; 101 (12): 2857-2865
6. Hommes DW, Sterringa G, van Deventer SJ et al. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004: 10 (3): 245-250
7. Maconi G, Colombo E, Zerbi P et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005; 37 (6): 418-423
8. Cottone M, Pietrosi G, Martorana G et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96 (3): 773-775
9. Criscuoli V, Casa A, Orlando A et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004; 36 (12): 818-820
10. Kishore J, Ghoshal U, Ghoshal UC et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004; 53 (Pt 11): 1155-1160
11. Issa M, Vijayapal A, Graham MB et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5 (3): 345-351
12. Rodemann JF, Dubberke ER, Reske KA et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5 (3): 339-344